Copper disrupts S-nitrosothiol signaling in activated BV2 microglia

Area of Science:

• Neuroimmunology
• Cellular Neuroscience
• Biochemistry

Background:

• Microglia are key immune cells in the central nervous system (CNS) that release nitric oxide (NO) in response to stimuli.
• S-nitrosoglutathione (GSNO) is the primary reservoir of biologically active NO, regulated by GSNO reductase (GSNOR).
• Copper (Cu(I)) has been shown to inhibit NO release and alter inflammatory profiles in activated microglia.

Purpose of the Study:

• To investigate the effect of Cu(I) on GSNOR activity and S-nitrosothiol (SNO) accumulation in activated microglia.
• To elucidate the mechanisms by which Cu(I) influences NO metabolism in the CNS.

Main Methods:

• LPS-stimulated BV2 microglia were treated with varying doses of Cu(I).
• GSNOR protein expression was assessed.
• S-nitrosothiol (SNO) content was measured.
• The interaction of Cu(I) with the SNO bond was investigated.

Main Results:

• Cu(I) treatment reduced GSNOR protein expression in LPS-stimulated BV2 microglia.
• A decrease in S-nitrosothiol (SNO) content was observed, despite reduced GSNOR expression.
• High doses of Cu(I) (100 μM) significantly inhibited SNO protein accumulation.
• Cu(I) likely degrades SNOs by reacting with the thiol group in the SNO bond.

Conclusions:

• Cu(I) disrupts S-nitrosothiol homeostasis and nitric oxide (NO) metabolism in activated microglia.
• These findings provide novel insights into the role of copper in microglia-mediated central nervous system (CNS) disorders.
• Understanding these mechanisms is crucial for developing therapeutic strategies for neuroinflammatory conditions.